icon_advocacy-orange_0.png
Advocacy
Promoting cancer in global health and development agendas.
Long_Term_Vision_2035_headlines@2x.png

In 2018, an estimated 18.1 million people were newly diagnosed with cancer. It is expected that by 2030, this number will rise to 21.6 million. This alarming trend can be reversed with strong action at global and national level. 

Investing in cancer control, from prevention to treatment and care, can bring about important changes in disease burden by reducing cancer-related illness and death. It is estimated that increased annual international funding of USD 18 billion globally on prevention, earlier detection and improved care for cancer patients could save three million lives per year by 2030 - and many more in the decades beyond.  

What is cancer control advocacy?

Advocacy for cancer control is a strategic process that is designed to influence governments, decision makers and other key stakeholders through the effective use of evidence, to reduce the global cancer burden, to promote greater equity, and to integrate cancer control into the world health and development agenda.

Advocacy at UICC

UICC unites the cancer community through our members and partners to reduce the global cancer burden and drive forward the Non-Communicable Disease (NCD) agenda - building upon key international agreements, such as the Sustainable Development Goals (SDGs), the Global Action Plan on NCDs 2013-2020, the World Cancer Declaration and the 2017 Cancer Resolution -  to ensure that these global goals and targets are translated into national action.

In addition to all countries developing and implementing an appropriately resourced and time-bound national cancer plan, we wish to see measurable improvements in the way that cancers are detected, treated and cured around the world. 

With global cancer burden trends on the rise, advocacy at UICC is shifting its immediate attention to Treatment for All, a campaign emphasising improved data, early detection, treatment and care to meet our global commitment of a 25% reduction in cancer and NCD mortality by 2025.

The importance of the advocacy work

"We are proud to call ourselves one of the first partners of UICC. UICC called on our expertise in the area of cancer prevention for the global advocacy campaign. Together, UICC and its members have successfully placed cancer on the global stage, putting the cancer community in position for even greater success in the years to come.”

Dr Kate Allen, Director, Science and Communications

"Accurate and timely diagnosis is the first enemy of cancer, as it clips its potential from the outset and halts it from invading and conquering the whole body. Unfortunately, many cancer patients, especially in the developing world, do not have this safety net, and are completely exposed to cancer’s advances without any checks. We need a robust cancer resolution that encourages fast improvements in early detection and diagnosis through a clear and urgent health system response."

HRH Princess Dina Mired
Help us &
get involved
icon_advocacy-orange_0.png

Show your support for 

UICC_Resource_Document_Solid_Icon_White-LightOrange_200px.png

the cancer resolution

This month, UICC announced its call for 2019 Country Champions and Mentors. Join the campaign to contribute toward reducing premature mortality and improving patient outcomes. https://www.uicc.org/NationalActivation Together, we can make a difference.

Key advocacy initiatives
WCDec_Report_2016_front_cover.jpg

World Cancer Declaration Progress Report 2016

The 1000-strong UICC membership have worked collectively to create the World Cancer Declaration Progress Report 2016, providing a unique civil society perspective on national successes and major challenges that remain to realise the Declaration targets, with perspectives from 113 countries.

Global Cancer Commitments Navigator

Navigator image.png

The navigator highlights the links between international, time-bound commitments to build compelling arguments for national action on cancer.

Explore our work
Advocacy landscape
Treatment for All
Global Action
National activation
Advocacy networks
Advocacy resources
Last update: 
Wednesday 10 April 2019
Share
Latest advocacy news
Women in the Instanbul Oncology Institute getting cancer treatment
24 January 2020

The importance of affordable and quality assured biosimilars

Access to timely and quality assured cancer treatment is crucial for successful outcomes and decreasing the global cancer burden. Fortunately, new and innovative treatments for many cancers are constantly being developed.

Cervical Cancer, UNITAID, Expertise France, Cervical Cancer Elimination
20 December 2019

Unitaid and Expertise France to intensify cervical cancer prevention

The Union for International Cancer Control (UICC) highly welcomes the announcement of Unitaid and Expertise France to intensify cervical cancer prevention in Burkina Faso, Cote d’Ivoire, Guatemala and the Philippines.

Man with a moustache for Movember supporting men's health
21 November 2019

The Movember Movement - Changing the face of men's health

The Movember campaign has inspired over five million men to grow moustaches each November since 2003. In that time, those men have raised funds for hundreds of programmes to tackle the issue of prostate cancer.

Room, Child, Furniture, Product, Baby Products, Toddler, Bed, Nursery, Infant bed, Baby safety
20 November 2019

Giving every child the chance to overcome cancer

World Children’s Day on 20 November is observed to promote the rights and well-being of children. This includes their right to health and access to quality treatment.

People smiling in African village
5 November 2019

Cancer control in Africa: paving the way to Universal Health Coverage

Where you live still determines your chances of surviving cancer. There are striking differences in the mortality rates and in the prevalence of certain cancer types across the world.

A collection of different e-cigarette/vaping devices
9 October 2019

E-cigarettes: effective cessation tool or new gateway to smoking tobacco?

Approximately 40 million people use e-cigarettes worldwide, a market that allows tobacco companies to generate significant revenues. (Source: Euromonitor international) Simultaneously, more and more health experts are raising questions about potential risks.